SUBSCRIBE
SUBSCRIBE
News   FDA

Novartis Corporation’s MS Drug Gets Approval in EU

May 27, 2008 | 
1 min read
ZURICH, May 26 (Reuters) - Swiss drugmaker Novartis said on Monday its Extavia multiple sclerosis drug had been approved in the European Union and repeated that it planned to launch Extavia in the U.S. and Europe in the first half of 2009.
FDA Approvals Europe
MORE ON THIS TOPIC
Success to win in business competition, overcome obstacles or motivation to solve problem and lead company achievement concept, confident businessman leader jump high over 3 hurdles to be winner.
Approvals
Biogen Bounces Back With FDA Nod for High-Dose Spinal Muscular Atrophy Drug
March 30, 2026
 · 
3 min read
 · 
Tristan Manalac
FDA
Webinar: Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises
March 27, 2026
 · 
1 min read
 · 
Heather McKenzie
Innovation - Think differently - Being different, taking risky, move for success in life -The graphic of rocket also represents the concept of courage, enterprise, confidence, belief, fearless, daring,
Gene therapy
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
March 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Silhouette of a business person on the top of a mountain peak in sunset background. Winner and conquer of businessman concept.
Approvals
Denali Delivers ‘Welcome Positive’ for Rare Disease Space With FDA’s Hunter Syndrome Nod
March 26, 2026
 · 
3 min read
 · 
Tristan Manalac